Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on CURTIS BANKS GROUP PLC. We currently have 3 research reports from 2 professional analysts.
|23Mar17 07:00||RNS||Final Results|
|02Mar17 07:00||RNS||Notice of Results|
|05Jan17 11:49||RNS||Director/PDMR Shareholding|
|30Dec16 12:20||RNS||Director/PDMR Shareholding|
|15Dec16 18:07||RNS||Director/PDMR Shareholding|
|09Nov16 17:11||RNS||Director/PDMR Shareholding|
|02Nov16 15:27||RNS||Exercise of Options|
Frequency of research reports
Research reports on
CURTIS BANKS GROUP PLC
CURTIS BANKS GROUP PLC
Small Cap Breakfast
23 Mar 17
K3 Capital Group—Schedule 1 from the Group of business and company sales specialists across business transfer, business brokerage and corporate finance. Admission date and fundraise details TBC. Integumen— Schedule 1 from the personal health company developing and commercialising technology and products for the human integumentary system. Raising £2.16m at 5p. Expected market cap £8.16m. Admission expected 5 April. Sentinel—Investment company expecting NEX admission/introduction on 24 March. £636k raised pre-IPO. BioPharma Credit—Expected Gross Initial Acquisition Proceeds now c.$338m. Gross Cash Proceeds capped at $423m with placing and open offer. Results expected 23 March with admission now due 30 march.
Happy Birthday AIM: it’s tough being the middle child
02 Dec 15
Going into 2015, AIM had monumental expectations. 2014 was a record breaking year for London’s junior market with IPOs across the year raising £2.4bn (the largest since AIM’s inception). AIM’s 20th year made for a perfect battle ground between the bull and bear camps once more. The bulls, hailing the success of the world’s most successful growth market referencing Big Yellow, IP Group, Domino’s Pizza and of course ASOS. The bears, swiftly retorting back sending shudders down the spines of investors everywhere with the sounds of Quindell, Globo, Adgorithms, and of course where would they be without the mention of a handful of China frauds.
10 Sep 15
Curtis Banks’s (CBP) first interim results since listing on AIM on 7 May 2015 show that both revenues and operating profit grew 66% year-on-year to £7.5m and £2.5m respectively. Basic EPS rose by 71% to 4.57p. The key growth driver was pre-IPO acquisitions. In a fragmented and growing market, with strong regulatory pressure on smaller participants, there is plenty of scope for further acquisitive and organic growth.
Another positive verdict
20 Mar 17
Burford’s results for 2016 produced another outstanding set of figures. Revenue grew by 60% to $163.4m with strong growth in the litigation finance business and an additional boost from a secondary sale in the Petersen case. On an underlying basis net income grew to $114m, a 75% increase despite the investment in growing capacity which increased costs. A combination of ongoing investment and gains and increases on valuation saw the fair value of the litigation assets increase 67% to $559m, underpinned by a growth in invested capital to $394m. With the results statement there was an announcement of a further sale of 9% of the Petersen case at a valuation of 20 times the cost of investment.
N+1 Singer - Morning Song 22-03-2017
22 Mar 17
Carador Income Fund (CIFU LN) Premium rating restored, high levels of refinancing activity | Cello Group (CLL LN) Outlook getting brighter – watch Pulsar | Eckoh (ECK LN) Largest ever US secure payments win | eg solutions (EGS LN) Full year results in line | Futura Medical (FUM LN) Licensing deal for CSD500 in Portugal | Verona Pharma (VRP LN) Global agreement with QuintilesIMS to support development of RPL554 | Xaar (XAR LN) 2016 results slightly ahead, reduced visibility in 2017
N+1 Singer - N1S Trend spotting - Strategy update
08 Mar 17
In this new product we present some strategy theme updates arising out of our latest analysis of macro trends and economic data and our innovative Quant work. We also look at upcoming events and suggest topping up on some of our Best Ideas for 2017.